Concepedia
Statistics
Publications
10
Citations
684
H-Index
Active since
2017
Affiliations
Universitätsklinikum Erlangen(Current)
Friedrich-Alexander-Universität Erlangen-Nürnberg
Johannes Gutenberg University Mainz
LMU Klinikum
Ludwig-Maximilians-Universität München
Alvaro Moreira is an author at Universitätsklinikum Erlangen specializing in oncology, cancer immunotherapy, and cancer immunology.
Publications per year
2017–2024
Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors
Alvaro Moreira, Carmen Loquai, Claudia Pföhler et al. · European Journal of Cancer · 2018 · 235 citations
Life Sciences, Immunology, Pharmacotherapy +14
Eosinophilic Count as a Biomarker for Prognosis of Melanoma Patients and Its Importance in The Response to Immunotherapy
Alvaro Moreira, Waltraud Leisgang, Gerold Schuler et al. · Immunotherapy · 2017 · 150 citations
Life Sciences, Immunology, Oncology +17
Hematological immune related adverse events after treatment with immune checkpoint inhibitors
Rafaela Kramer, Anne Zaremba, Alvaro Moreira et al. · European Journal of Cancer · 2021 · 94 citations
Medicine, Hematology, Oncology +14
Senescence markers: Predictive for response to checkpoint inhibitors
Alvaro Moreira, Michael Constantin Kirchberger, Michael Erdmann et al. · International Journal of Cancer · 2018 · 58 citations · Full text
Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients
Michael Constantin Kirchberger, Alvaro Moreira, Michael Erdmann et al. · Oncotarget · 2018 · 46 citations · Full text
Medicine, Dermatology, Oncology +17
1–5 of 10